Pulmonary vascular K+ channel expression and vasoreactivity in a model of congenital heart disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 6 27-6, 2002, Pages

  Cornfield, David N ^a   Resnik, Ernesto R ^a   Herron, Jean M ^a   Reinhartz, Olaf ^b   Fineman, Jeffrey R ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcium sensitive potassium channel; PH sensitive potassium channel; Pulmonary hypertension; Vascular reactivity

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; POTASSIUM CHANNEL;

ALKALOSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; GENE EXPRESSION; HYPOXIA; LUNG ARTERIOVENOUS SHUNT; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; NEWBORN; NONHUMAN; OXYGEN TENSION; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SHEAR STRESS; SHEEP; VASODILATATION;

EID: 0036892409     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00428.2001     Document Type: Article

References (37)

1. Abman SH, Chatfield BA, Hall SL, and McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol Heart Circ Physiol 259: H1921-H1927, 1990.
2. Adatia I, Barrow SE, Stratton PD, Miall-Allen VM, Ritter JM, and Haworth SG. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation 88: 2117-2122, 1993.
3. Adatia I and Haworth SG. Circulating levels of endothelin-1 in children with congenital heart disease. Br Heart J 69: 233-238, 1993.
4. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, and Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients wth pulmonary hypertension. J Am Coll Cardiol 25: 1656-1664, 1995.
5. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, and Abman SH. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 148: 519-522, 1993.
6. Archer SL, Huang JM-C, Hampl V, Nelson DP, Shultz PJ, and Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994.
7. Archer SL, Huang JM-C, Henry T, Peterson D, and Weir EK. A redox based oxygen sensor in rat pulmonary vasculature. Circ Res 73: 370-378, 1993.
8. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial nitric oxide-synthase in lambs with increased pulmonary blood flow and pulmonary hypertension: Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
9. Celermajer DS, Cullen S, and Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease. Circulation 87: 440-446, 1993.
10. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, and Kourembanas S. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 130: 603-611, 1997.
11. Cook J, Rossitch JE Jr, Andon N, and Dzau V. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88: 1663-1671, 1991.
12. Cook N. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 9: 21-28, 1988.
13. Cornfield DN, Reeve HL, Tolarova S, Weir EK, and Archer SL. Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci USA 93: 8089-8094, 1996.
14. Cornfield DN, Resnik ER, Herron JM, and Abman SH. Chronic intrauterine pulmonary hypertension decreases calcium-sensitive potassium channel expression. Am J Physiol Lung Cell Mol Physiol 279: L857-L862, 2000.
15. + channel activity in the ovine pulmonary vasculature is developmentally regulated. Am J Physiol Lung Cell Mol Physiol 278: L1297-L1304, 2000.
16. Fullerton DA, Jaggers J, Piedalue F, Grover FL, and McIntyre RCJ. Effective control of refractory pulmonary hypertension after cardiac operations. J Thorac Cardiovasc Surg 113: 363-368, 1997.
17. Giad A and Saleh D. Reduced expression of endothelial nitric oxide synthase in lungs of patinets with pulmonary hypertension. N Engl J Med 333: 214-221, 1995.
18. Heath D and Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary artery with special reference to congenital cardiac septal defect. Circulation 18: 533-550, 1958.
19. Hoffman JIE, Rudolph AM, and Heymann MA. Pulmonary vascular disease with congenital heart lesions: Pathologic features and causes. Circulation 64: 873-877, 1981.
20. + channels in aorta of hypertensive rats. Hypertension 30: 1403-1409, 1997.
21. Rabinovitch M, Haworth SG, Castenada AR, Nadas AS, and Reid LM. Lung biopsy in congenital heart disease in children: A morphometric approach to vascular disease. Circulation 58: 1107-1122, 1978.
22. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hamnley FL, and Fineman JR. In utero placement of aortopulmonary shunts: A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613, 1995.
23. Reddy VM, Wong J, Liddicoat JR, Johengen M, Chang R, and Fineman JR. Altered endothelium-dependent vasoactive responses in lambs with pulmonary hypertension and increased pulmonary bloodflow. Am J Physiol Heart Circ Physiol 271: H562-H570, 1996.
24. + channel from human kidney. J Biol Chem 273: 30863-30869, 1998.
25. Rhodes MT, Porter VA, Saqueton CB, Herron JM, Resnik ER, and Cornfield DN. Pulmonary vascular response to normoxia and KCa channel activity is developmentally regulated. Am J Physiol Lung Cell Mol Physiol 280: L1250-L1257, 2001.
26. Rudolph A. Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 57: 811-821, 1985.
27. Rudolph AM, Kurland MD, Auld PAM, and Paul MH. Effects of vasodilator drugs on normal and serotonin-constricted pulmonary vessels of the dog. Am J Physiol 197: 617-623, 1959.
28. Rusch NJ and Runnels AM. Remission of high blood pressure reverses arterial potassium channel alterations. Hypertension 23: 941-945, 1994.
29. + channel activation and requires intracellular calcium release. Am J Physiol Lung Cell Mol Physiol 276: L925-L932, 1999.
30. i. Am J Physiol Heart Circ Physiol 266: H1416-H1421, 1994.
31. + channel blockade inhibits shear stress-induced pulmonary vasodilation in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 276: L220-L228, 1999.
32. Tristani-Firouzi M, Martin EB, Tolarova S, Weir EK, Archer SL, and Cornfield DN. Ventilation-induced pulmonary vasodilation at birth is modulated by potassium channel activity. Am J Physiol Heart Circ Physiol 271: H2353-H2359, 1996.
33. Vaca L, Licea A, and Possani LD. Modulation of cell membrane potential in cultured vascular endothelium. Am J Physiol Cell Physiol 270: C819-C824, 1996.
34. Van Breemen C and Saida K. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol 51: 315-329, 1989.
35. 2+-dependent modulators mediate alkalosis-induced vasodilation in newborn piglet lungs. Am J Physiol Lung Cell Mol Physiol 280: L519-L526, 2001.
36. Yuan X-J, Goldman WF, Tod ML, Rubin LJ, and Blaustein MP. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol Lung Cell Mol Physiol 264: L116-L123, 1993.
37. + channels in rat pulmonary artery smooth muscle cells. Exp Physiol 80: 803-813, 1995.